维持性血液透析患者疲乏影响因素及其与心理弹性、希望之间的相关性分析

目的 了解维持性血液透析(MHD)患者的心理弹性、希望和疲乏现状,分析心理弹性在希望与疲乏之间的作用.方法 采用便利抽样方法,于2019年9-10月选择杭州市中医院肾病科符合纳入排除标准的120例MHD患者进行问卷调查,调查问卷包括患者一般资料调查表、Piper疲乏修订量表、Herth希望量表及心理弹性量表,调查人员采...     

Efficacy of peficitinib in two patients with rheumatoid arthritis on maintenance hemodialysis

Objective: Treatment options for patients with rheumatoid arthritis on maintenance hemodialysis with an inadequate response to biologic agents have not been reported. In this report, we describe two patients who achieved remission after treatment with peficitinib.Methods: Two 69- and 85-year-old patients with rheumatoid arthritis on maintenance hemodialysis were previously treated with biologics and started on peficitinib 100 mg/day after the secondary failure of biologics.Discussion: In the two cases presented here, rheumatoid arthritis was almost in remission and there were no adverse events, although the patients were switched to peficitinib after secondary failure of the biologic agents. Among Janus kinase inhibitors, peficitinib has the lowest renal excretion; therefore, its administration in patients on dialysis is not contraindicated according to the package insert in Japan. The use of biologic agents in patients on hemodialysis has been reported to be associated with a high incidence of infections; therefore, care should be taken to avoid infections when administering Janus kinase inhibitors.Conclusion: Janus kinase inhibitors with low renal excretion, such as peficitinib, may be effective in patients with rheumatoid arthritis on maintenance hemodialysis who have an inadequate response to biologic agents.     

1598例经颈内静脉带隧道中心静脉导管置入术分析

目的 探讨颈内静脉入路的带隧道中心静脉导管置管准确性和安全性的影响因素. 方法 回顾性分析2011年～2019年行颈内静脉带隧道中心静脉导管置入术的病例资料.收集人口学资料,手术相关资料,包括置管位置,是否用X线,置管失败原因,介入干预情况,干预失败原因等.研究主要终点是置管成功率和失败原因. 结果 1598例患者纳入...     

透刺法治疗膝骨关节炎疗效观察

目的比较透刺法与常规针法治疗膝关节骨性关节炎的疗效差异。方法将111例膝关节骨性关节炎患者分为透刺法组(81例)与常规针法组(30例)进行治疗。结果透刺法组痊愈率69.14%,常规针法组痊愈率16.67%,两组比较差异有统计学意义(P<0.01)。结论透刺法治疗膝关节骨性关节炎的效果优于传统针刺法。     

Effects of hemodialysis and reduced estimated glomerular filtration rate in nonhemodialysis on clinical outcomes after fractional flow reserve-guided deferral of revascularization

The effect of renal dysfunction on clinical outcomes following fractional flow reserve (FFR)-guided deferral of revascularization remains unelucidated.We retrospectively analyzed 224 patients with atherosclerotic coronary lesions who underwent deferred revascularization based on an FFR of >0.80. The median follow-up interval was 28.1 months. Patients were divided into 2 groups: the hemodialysis (HD) and the non-HD group. The non-HD group was further classified into 2 subgroups according to their estimated glomerular filtration rate (eGFR) level: eGFR <45, equivalent to chronic kidney disease stage 3b-5 and eGFR ≥45. We evaluated major adverse cardiac events (MACE), defined as a composite of cardiac death, myocardial infarction, and any revascularization.MACE occurred in 36 patients (16.1%). The rate of HD was significantly higher in the MACE group (19% vs 6%, P < .01). In non-HD patients, the eGFR was significantly lower in the MACE group (51.2 vs 63.2 mL/min/1.73 m², P < .01). Overall, univariate Cox regression analysis revealed a significant relationship between HD and MACE (HR 2.91, P = .01), as did the multivariate model (HR 2.90, P = .01). Of the MACE, more deaths occurred in HD patients (15.8% vs 2.9%, P = .03). Among non-HD patients, eGFR <45 (HR 2.70, P = .02), FFR (per 0.01, HR 0.87, P < .01), and low-density lipoprotein cholesterol (per 10 mg/dL, HR 1.17, P = .02) were independent predictors of MACE. Any revascularization was more common in patients with eGFR<45 than in those with eGFR ≥45 (21.4% vs 7.3%, P = .02). Kaplan–Meier estimates revealed that the HD group showed a significantly lower MACE-free survival rate than the nonHD group (log-rank P < .01). In non-HD patients, the eGFR<45 group showed a lower MACE-free survival rate than the eGFR ≥45 group (log-rank P = .01).HD and reduced eGFR in non-HD patients were associated with adverse cardiac events after FFR-guided deferral of revascularization.     

饮食护理对糖尿病肾病维持性血液透析患者营养状况和并发症的影响评价

目的 评价饮食护理对糖尿病肾病维持性血液透析患者营养状况和并发症的影响.方法 在2019年6月—2020年6月期间选取92例糖尿病肾病维持性血液透析患者作为研究对象,电脑随机分为两组,对照组给予常规护理,观察组加强饮食护理,分析对患者营养状况及并发症的影响.结果 护理后,观察组ALB、PA、TR、DPI、nPCR水平高...     

自体动静脉内瘘血栓危险因素的Meta分析

目的 明确血液透析患者发生自体动静脉内瘘血栓(arteriovenous fistulas thrombus, AVFT)的危险因素,为预防血液透析患者AVFT的发生提供依据.方法 计算机检索Cochrane Library、 PubMed、Embase、Web Of Science、中国知网、万方数据库、维普数据库和...     

基于依从性曲线变化规律的分阶段健康指导在维持性血液透析病人中的应用

目的:探讨基于依从性曲线变化规律的分阶段健康指导在维持性血液透析病人中的应用效果。方法:将168例行维持性血液透析治疗的慢性肾病病人根据透析时间将病人分为对照组和观察组,每组84例,对照组行常规健康指导,观察组基于依从性曲线变化规律对病人实施健康指导,比较两组病人干预前后遵医行为、自我护理能力及血液透析并发症发生率。结果:干预后观察组病人遵医行为总分及各维度评分(合理饮食、控制液体摄入、血管通路维护、日常生活管理、规律运动、定期门诊随访)较对照组明显提高(P<0.05);干预后观察组病人自我护理能力总分及相关维度评分较对照组明显提高(P<0.05);观察组病人并发症发生率低于对照组(P<0.05)。结论:基于依从性曲线变化规律的分阶段健康指导能有效提高维持性血液透析病人遵医行为及自我护理能力,从而降低病人血液透析并发症发生率。     

卵巢低反应获卵患者常规体外受精与卵胞浆单精子注射技术对妊娠结局的影响

目的比较卵巢低反应获卵患者常规体外受精与卵胞浆单精子注射技术对妊娠结局的影响。方法选择卵巢低反应获卵患者200例,将其分为两组,各100例。观察组采用卵胞浆单精子注射技术,对照组则实施常规体外受精技术,比较两组的移植结果及继续妊娠情况,并对着床患者随访1年,统计妊娠结局。结果观察组的受精率、可移植胚胎率、着床率、继续妊娠率均分别显著高于对照组（P〈0.05）;观察组的单胎妊娠率高于对照组,双胎妊娠、异位妊娠率低于对照组（P〈0.05）。结论对卵巢低反应获卵的不孕患者行卵胞浆单精子注射技术,相对于常规体外受精,具有更高的卵裂率和继续妊娠率,为卵巢低反应获卵的不孕患者采取何种受精方式提供了一个选择依据。     

盐酸替罗非班应用于冠心病治疗中的疗效分析

目的：分析盐酸替罗非班应用于冠心病治疗中的疗效,为临床提供依据。方法选取2015年8月至2016年6月我院诊治的冠心病患者120例,依据治疗方法的不同,将患者按照随机表法,随机分为对照组和观察组,每组各60例。对照组采用常规方法治疗,观察组联合采用盐酸替罗非班进行治疗,比较两组治疗效果。结果观察组治疗总有效率,显著高于对照组（P<0.05）;两组患者手术前疼痛评分差异不具有统计学意义（P>0.05）;观察组术后疼痛评分显著低于对照组（P<0.05）。结论与常规治疗方法相比,联合采用盐酸替罗非班治疗冠心病的效果理想,能加速患者康复,术后疼痛感减轻,并发症发生率低,在临床上值得推广应用。